New drug ALMB-0166 tested for spinal cord injury safety
NCT ID NCT05524103
First seen Nov 18, 2025 · Last updated May 15, 2026 · Updated 28 times
Summary
This early-stage study tested a single dose of the drug ALMB-0166 in 24 adults who had a recent spinal cord injury. The main goal was to see if the drug is safe and how the body processes it. Participants received either the drug or a placebo after spinal surgery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE SPINAL CORD INJURY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Peking University Third Hospital
Beijing, Beijing Municipality, China
-
Peking University Third Hospital Medical Science Research Ethic Committee
Beijing, Beijing Municipality, 100191, China
Conditions
Explore the condition pages connected to this study.